Li et al. showed that BBR inhibited colonic epithelium hyperproliferation and colitis-associated tumorigenesis in colitis-associated colorectal cancer (CACRC) mice model by inhibiting tumor necrosis factor-α (TNF-α) and IL-6 expression in colonic macrophages. Here, IL6 is linked to colitis.